JD

Jonathan David Perl

Active Director Director DIN 11805215
DIN 11805215 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Jonathan David Perl

Jonathan David Perl is a Director at Lifebot Health Private Limited (since 2026).

DIN 11805215
Primary Designation Director
First Appointment 04 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lifebot Health Private Limited U86909KA2026FTC223394
Director04 Jul 20262026Active

Board colleagues of Jonathan David Perl

NameDINCompanyDesignation
David Abikzir03160720Lifebot Health Private LimitedDirector
Martin Jay Perl11805216Lifebot Health Private LimitedDirector
Martin PerlLifebot Health Private LimitedNon- Individual Subscriber

Directorship timeline

Open interactive timeline →
Lifebot Health Private Limited
Premium access

Shareholding and investment profile for Jonathan David Perl

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jonathan David Perl

Jonathan David Perl currently holds 1 directorship: Lifebot Health Private Limited (Director, since 04 Jul 2026).

Jonathan David Perl was first appointed on 04 Jul 2026 as Director at Lifebot Health Private Limited.

The current boards of Jonathan David Perl's companies include David Abikzir (Lifebot Health Private Limited), Martin Jay Perl (Lifebot Health Private Limited), Martin Perl (Lifebot Health Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available